drugset / Trial / NCT05899699

Effect of New Topical Preparation for Treatment of Acne Vulgaris

NCT05899699

Phase 2 Unknown 20 enrolled Mansoura University
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators propose a randomized, double-blind control trial study to evaluate the efficacy and safety of the optimized topical combination ME of the investigated drugs in the treatment of acne vulgaris containing DAP-FLU in comparison with standard therapy of Adapalene at Mansoura University Dermatology and Andrology Outpatient Clinic.

Timeline

Start
2023-06-05
Primary completion
2023-09-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adapalene Other / unclassified 0.1 %
Subject Dapsone Small molecule 5 % Topical
Subject flutamide Small molecule 2.5 % Topical
Subject tea tree oil Unknown 5 % Topical

Indications